DE2514229A1 - 1,1-diaryl-1-oxadiazol-alkylamine - Google Patents

1,1-diaryl-1-oxadiazol-alkylamine

Info

Publication number
DE2514229A1
DE2514229A1 DE19752514229 DE2514229A DE2514229A1 DE 2514229 A1 DE2514229 A1 DE 2514229A1 DE 19752514229 DE19752514229 DE 19752514229 DE 2514229 A DE2514229 A DE 2514229A DE 2514229 A1 DE2514229 A1 DE 2514229A1
Authority
DE
Germany
Prior art keywords
radical
carbon atoms
diphenyl
propyl7
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19752514229
Other languages
German (de)
English (en)
Inventor
Gilbert William Adelstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of DE2514229A1 publication Critical patent/DE2514229A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
DE19752514229 1974-04-01 1975-04-01 1,1-diaryl-1-oxadiazol-alkylamine Ceased DE2514229A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US456755A US3917615A (en) 1974-04-01 1974-04-01 1,1-Diaryl-1-oxadiazol-alkylamines

Publications (1)

Publication Number Publication Date
DE2514229A1 true DE2514229A1 (de) 1975-10-09

Family

ID=23814026

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19752514229 Ceased DE2514229A1 (de) 1974-04-01 1975-04-01 1,1-diaryl-1-oxadiazol-alkylamine
DE19752514183 Withdrawn DE2514183A1 (de) 1974-04-01 1975-04-01 1,1-diaryl-1-oxadiazol-alkylamine

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19752514183 Withdrawn DE2514183A1 (de) 1974-04-01 1975-04-01 1,1-diaryl-1-oxadiazol-alkylamine

Country Status (26)

Country Link
US (2) US3917615A (enExample)
JP (2) JPS5936631B2 (enExample)
AR (2) AR206425A1 (enExample)
AT (2) AT340916B (enExample)
BE (2) BE827323A (enExample)
CA (2) CA1067498A (enExample)
CH (2) CH613964A5 (enExample)
CS (1) CS194718B2 (enExample)
DE (2) DE2514229A1 (enExample)
DK (2) DK137275A (enExample)
EG (1) EG12104A (enExample)
ES (2) ES436044A1 (enExample)
FI (2) FI61895C (enExample)
FR (2) FR2265376B1 (enExample)
GB (2) GB1456943A (enExample)
HU (1) HU170747B (enExample)
IE (2) IE40894B1 (enExample)
IL (2) IL46959A (enExample)
NL (2) NL7503849A (enExample)
NO (2) NO142173C (enExample)
OA (1) OA04914A (enExample)
PH (1) PH11423A (enExample)
PL (1) PL99553B1 (enExample)
SE (2) SE420492B (enExample)
YU (1) YU39200B (enExample)
ZA (2) ZA751193B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194045A (en) * 1977-12-27 1980-03-18 G. D. Searle & Co. 1-(3,3-Diaryl-3-oxadiazolalkyl)-4-phenyl-4-piperidinomethanols and related compounds

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003904A (en) * 1974-04-01 1977-01-18 G. D. Searle & Co. Anti-diarrheal oxadiazoles
US3998832A (en) * 1975-04-16 1976-12-21 G. D. Searle & Co. Anti-diarrheal compounds
US4057549A (en) * 1975-04-16 1977-11-08 G. D. Searle & Co. Triarylpropyl-azabicyclooctanes
US4086227A (en) * 1975-04-16 1978-04-25 G. D. Searle & Co. Novel anti-diarrheal 4-azatricyclo[4.3.1.13,8 ] undecane derivatives
US4025524A (en) * 1975-04-16 1977-05-24 G. D. Searle & Co. 2-{3-[4-Azatricyclo(4.3.1.13,8)undecan-4-yl]-1,1-diphenylpropyl}-5-methyl-1,3,4-oxadiazole and congeners
US3996214A (en) * 1976-02-23 1976-12-07 G. D. Searle & Co. 5-(1,1-Diphenyl-4-(cyclic amino) but-2-trans-en-1-yl)-2-alkyl-1,3,4-oxadiazoles and intermediates thereto
US4013668A (en) * 1976-03-10 1977-03-22 G. D. Searle & Co. 5-(1,1-diphenyl-3-(5- or 6-hydroxy-2-azabicyclo(2.2.2)oct-2-yl)propyl)-2-alkyl-1,3,4-oxadiazoles and related compounds
US4012393A (en) * 1976-03-22 1977-03-15 G. D. Searle & Co. 2-[5-(CYCLIC AMINO) ETHYL-10,11-DIHYDRO-5H-dibenzo[a,d]-cyclohepten-5- yl]-5
US4028364A (en) * 1976-07-06 1977-06-07 G. D. Searle & Co. 2-Azabicyclo[2.2.2.]octan-2-yl-diphenyl-alkanones and related compounds
US4053477A (en) * 1976-09-20 1977-10-11 G. D. Searle & Co. 5-(1,1-diphenyl-3-(4-phenylpiperidino)propyl)-2-methyl-1,3,4-oxadiazole and related compounds
US4203990A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal 2-substituted quinuclidines
US4203989A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal diaryl-(1-azabicyclo(2.2.2)octan-2-yl)-alkanols and related compounds
US4596801A (en) 1983-03-24 1986-06-24 Chugai Seiyaku Kabushiki Kaisha 4H-3,1-benzoxazine derivatives, process for producing the same and agricultural or horticultural fungicide containing the same
JPS61194917A (ja) * 1985-02-23 1986-08-29 Matsushita Electric Works Ltd 遅れスイツチ
JPS61195022A (ja) * 1985-02-25 1986-08-29 Matsushita Electric Works Ltd 遅れスイツチ
GB8830226D0 (en) * 1988-12-23 1989-02-22 Beecham Group Plc Novel compounds
DK40890D0 (da) * 1990-02-16 1990-02-16 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
US5889038A (en) * 1996-03-20 1999-03-30 Children's Hospital Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
BR122015009423A2 (pt) 2011-05-27 2019-01-22 Reliance Industries Ltd. hidrólise e esterificação com catalisadores ácidos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3141019A (en) * 1964-07-14 Chaohj
US3299044A (en) * 1964-05-13 1967-01-17 Searle & Co Complex n-substituted azabicycloalkanes
FR1469022A (fr) * 1965-12-14 1967-02-10 Chimie Et Synthese De Picardie Nouveaux dérivés oxadiazoliques et leur procédé de préparation
GB1174411A (en) * 1966-03-02 1969-12-17 Aspro Nicholas Ltd Novel Benzothiophen Compounds, Compositions containing them and processes for their manufacture
GB1231829A (enExample) * 1968-09-19 1971-05-12
US3720685A (en) * 1970-07-15 1973-03-13 Squibb & Sons Inc 3-amino-5-benzyl-1,2,4-oxadiazoles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194045A (en) * 1977-12-27 1980-03-18 G. D. Searle & Co. 1-(3,3-Diaryl-3-oxadiazolalkyl)-4-phenyl-4-piperidinomethanols and related compounds

Also Published As

Publication number Publication date
SE420492B (sv) 1981-10-12
YU39200B (en) 1984-08-31
DE2514183A1 (de) 1975-10-09
OA04914A (fr) 1975-10-31
JPS5939434B2 (ja) 1984-09-22
IL46966A0 (en) 1975-05-22
NO142174B (no) 1980-03-31
NL7503849A (nl) 1975-10-03
IE40895L (en) 1975-10-01
GB1494943A (en) 1977-12-14
ES436160A1 (es) 1977-02-01
IL46966A (en) 1977-11-30
IE40895B1 (en) 1979-09-12
IL46959A (en) 1978-03-10
EG12104A (en) 1978-06-30
GB1456943A (en) 1976-12-01
AR206425A1 (es) 1976-07-23
USRE29556E (en) 1978-02-28
CH614205A5 (enExample) 1979-11-15
FR2265376A1 (enExample) 1975-10-24
JPS5936631B2 (ja) 1984-09-05
NO751104L (enExample) 1975-10-02
FI61895C (fi) 1982-10-11
YU81675A (en) 1982-02-28
JPS50135086A (enExample) 1975-10-25
SE420491B (sv) 1981-10-12
IL46959A0 (en) 1975-05-22
HU170747B (enExample) 1977-08-28
CH613964A5 (enExample) 1979-10-31
FR2265376B1 (enExample) 1980-02-22
NL7503856A (nl) 1975-10-03
ZA751986B (en) 1976-06-30
AT340916B (de) 1978-01-10
NO751103L (enExample) 1975-10-02
SE7503689L (sv) 1975-10-02
AT342045B (de) 1978-03-10
BE827323A (fr) 1975-09-29
DK137275A (enExample) 1975-10-02
JPS50135081A (enExample) 1975-10-25
SE7503688L (sv) 1975-10-02
FR2265367A1 (enExample) 1975-10-24
NO142173C (no) 1980-07-09
FI63572C (fi) 1983-07-11
FI63572B (fi) 1983-03-31
CA1053672A (en) 1979-05-01
BE827324A (fr) 1975-09-29
FI61895B (fi) 1982-06-30
CS194718B2 (en) 1979-12-31
FI750966A7 (enExample) 1975-10-02
NO142174C (no) 1980-07-09
FR2265367B1 (enExample) 1978-07-28
NO142173B (no) 1980-03-31
PH11423A (en) 1978-01-09
ZA751193B (en) 1976-04-28
ATA245175A (de) 1977-05-15
IE40894L (en) 1975-10-01
IE40894B1 (en) 1979-09-12
AU7958575A (en) 1976-09-30
DK137375A (enExample) 1975-10-02
CA1067498A (en) 1979-12-04
AU7958475A (en) 1976-09-30
AR206341A1 (es) 1976-07-15
PL99553B1 (pl) 1978-07-31
ATA245275A (de) 1977-07-15
ES436044A1 (es) 1977-05-01
US3917615A (en) 1975-11-04
FI750965A7 (enExample) 1975-10-02

Similar Documents

Publication Publication Date Title
DE2514229A1 (de) 1,1-diaryl-1-oxadiazol-alkylamine
DE2414680C2 (de) Substituierte 2-Furancarbonsäuren und 2-Furancarbonsäureester, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
CH625243A5 (enExample)
DE2616616A1 (de) 1-(triarylalklyl)-4-phenylpiperidinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die diese verbindungen enthalten
DE2446100C3 (de) Phenoxyalkancarbonsäureamide von Thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und Arzneimittel
DE1212090B (de) Verfahren zur Herstellung von 10-(Piperazinopropyl)-3-trifluormethyl-phenothiazinverbindungen und ihren Salzen
DE2319834C3 (de) Derivate von 2-Carboxy-pyrazin-4-oxiden, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2022656B2 (de) 2-(Nicotinoylaminoäthansulfonylamino)pyridin
DE2456098C3 (de) Xanthen- und Thioxanthen-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1470123C3 (de) 4-(2,6-Dioxo-3-phenyl-3-piperidyl>piperidine, deren pharmakologisch verträgliche Säureadditionssalze und Verfahren zu ihrer Herstellung
DE2313256B2 (de) 1 ^-Benzisoxazol-3-acetamidoxim, seine Salze, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1620325C3 (de) Disubstituierte Isoxazolverbindungen
DD150060A5 (de) Verfahren zur herstellung von neuen phenthiazin-derivaten
DE2407016A1 (de) 2-alkoxybenzoylaminosaeuren, verfahren zur herstellung derselben und antipyretisches mittel mit einem gehalt derselben
DE3028291C2 (de) 3-Methylbenzo[b]furyl-2-acetamide und diese Verbindungen enthaltende Arzneimittel
DE2418574A1 (de) Pyrazolderivate, verfahren zu ihrer herstellung und arzneimittel
DE1289050B (de) Verfahren zur Herstellung von 3-(3'-Hydroxyphenyl)-1-phenacyl-piperidinen
DE2425306A1 (de) Imidazolido eckige klammer auf 1,5-c eckige klammer zu thiazolidin-3-spiro-4' -piperidin-derivate, ihre salze, verfahren zu ihrer herstellung und arzneimittel
DE1545764C (de) p Chlorphenvhsopropylcarbinol nico tinsaureester
DE3620215A1 (de) Benzamide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE1645901C3 (de) gamma-(4-Alkylp!peridino)-p-fluorbutyrophenone und Verfahren zu ihrer Herstellung
DE2423725A1 (de) 5-phenyl-4-oxo-delta hoch 2,alphathiazolidinessigsaeureester
DE1287582B (de) Verfahren zur Herstellung von disubstituierten Isoxazol-Verbindungen und ihrer nicht toxischen Salze
DE2022746A1 (de) Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung
DE2559558C3 (de) Apovincaminsäureamide, deren Salze mit Säuren, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection